This inability to activate IRF3 correlated with decreased expression of the interferon-stimulated gene IFITM2, examined in an expanded cohort of healthy, mild and moderate COVID-19 monocytes after stimulation with SARS-CoV-2 (Fig. 5h). This evidence concerns the gene IRF3 and COVID-19.